Search
March 11, 2022

CDC-Abt Study Shows Pfizer Vaccine Is Moderately Effective for Children

Body

More than 300 news organizations, including CBS and Forbes, quoted Abt’s Lauren Olsho explaining the benefits of our PROTECT study for the CDC, which gathers and tests nasal swabs weekly from children, regardless of whether they had COVID-19 symptoms. “Without regular weekly testing you will miss many infections, particularly for kids, who often have mild symptoms,” said Olsho, the study’s principal investigator. Other pediatric vaccine studies captured only symptomatic cases, and with more home testing, studies like Abt’s are needed for a comprehensive view of vaccine effectiveness, she noted.

Read More

COVID-19 in North America

APHSA Economic Mobility & Well-Being Conference 2026

Work requirements are expanding and budgets are not. Let's build an employment program that meets you where you're at.

Learn More
Event

2026 Defense Health Information Technology Symposium (DHITS)

Readiness is a data problem. We have solutions. Book a demo of our defense health data tools and meet our military health team. 

Learn More
Event

National Ryan White Conference 2026

RWHAP teams have settled the question of whether to use AI. The open question is where to start.

Learn More
Event

National Association of Conservation Districts (NACD) Summer Meeting

We’re headed to Grand Rapids to showcase conservation tools rooted in results and ready for the field.

Learn More
Event